Other small molecules of interest are immunomodulatory agents (IMIDs), as they do cross the BBB and have a cytotoxic activity through NF-kB pathway inhibition but also a modulating activity on the microenvironment, stimulating natural killer (NK) and T cells against the tumor [73]. This evidence concerns the gene NFKB1 and neoplasm.